GlobeNewswire 2025-11-12 Novartis Phase III trial for next-generation malaria treatment KLU156 (GanLum) meets primary endpoin...
GlobeNewswire 2025-11-12 Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
Newsfile Corp 2025-11-12 TMX Group Equity Financing Statistics - October 2025
GlobeNewswire 2025-11-12 ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Followin...
GlobeNewswire 2025-11-12 Autolus Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
GlobeNewswire 2025-11-12 Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights
GlobeNewswire 2025-11-10 Novartis opens new radioligand therapy manufacturing facility in California as part of $23B US expan...
GlobeNewswire 2025-11-10 Voyager Reports Third Quarter 2025 Financial and Operating Results
GlobeNewswire 2025-11-10 Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS...
GlobeNewswire 2025-11-10 Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Toward...
GlobeNewswire 2025-11-10 Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors
GlobeNewswire 2025-11-06 BioAge Labs Reports Third Quarter 2025 Financial Results and Provides Business Updates
GlobeNewswire 2025-11-06 Denali Therapeutics Announces Board and Executive Leadership Updates
GlobeNewswire 2025-11-06 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential U...
GlobeNewswire 2025-11-06 Genmab Announces Financial Results for the Nine Months of 2025
GlobeNewswire 2025-11-06 Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real...
GlobeNewswire 2025-11-06 Monte Rosa Therapeutics Announces Third Quarter 2025 Financial Results and Business Updates
GlobeNewswire 2025-11-06 Pharming Group reports third quarter 2025 financial results with significant growth in revenue, prof...
GlobeNewswire 2025-11-05 Royalty Pharma Reports Third Quarter 2025 Results
GlobeNewswire 2025-11-05 Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire 2025-11-04 Esperion Appoints Industry Veteran John Harlow as Chief Commercial Officer
GlobeNewswire 2025-11-04 New Novartis data at ASN Kidney Week and AHA Scientific Sessions demonstrate momentum of broad CRM p...
GlobeNewswire 2025-11-03 The Heart-Body Connection: How Other Organ Systems Affect Heart Health
GlobeNewswire 2025-11-03 Pond Lehocky Giordano Welcomes Nationally Recognized Litigator Jeremy Abay to Lead New Haddonfield O...
GlobeNewswire 2025-11-03 Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (AS...